Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.

× No keyword cloud information.

10 in total

1. Mortality in elderly dementia patients treated with risperidone.

Authors: Martin Haupt; Alfonso Cruz-Jentoft; Dilip Jeste
Journal: J Clin Psychopharmacol Date: 2006-12 Impact factor: 3.153

2. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Authors: Sanford Finkel; Chris Kozma; Stacey Long; Andrew Greenspan; Ramy Mahmoud; Onur Baser; Luella Engelhart
Journal: Int Psychogeriatr Date: 2005-10-05 Impact factor: 3.878

3. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics.

Authors: Rosa Liperoti; Giovanni Gambassi; Kate L Lapane; Claire Chiang; Claudio Pedone; Vincent Mor; Roberto Bernabei
Journal: J Clin Psychiatry Date: 2005-09 Impact factor: 4.384

4. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients.

Authors: W C Chan; L C Lam; C N Choy; V P Leung; S W Li; H F Chiu
Journal: Int J Geriatr Psychiatry Date: 2001-12 Impact factor: 3.485

5. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study.

Authors: Sudeep S Gill; Paula A Rochon; Nathan Herrmann; Philip E Lee; Kathy Sykora; Nadia Gunraj; Sharon-Lise T Normand; Jerry H Gurwitz; Connie Marras; Walter P Wodchis; Muhammad Mamdani
Journal: BMJ Date: 2005-01-24

Review 6. Managing the behavioral and psychological signs and symptoms of dementia.

Authors: S I Finkel
Journal: Int Clin Psychopharmacol Date: 1997-09 Impact factor: 1.659

7. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function.

Authors: I Hindmarch; Z Shamsi; N Stanley; D B Fairweather
Journal: Br J Clin Pharmacol Date: 1999-08 Impact factor: 4.335

8. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors: Lon S Schneider; Karen S Dagerman; Philip Insel
Journal: JAMA Date: 2005-10-19 Impact factor: 56.272

9. International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia.

Authors: Dilip V Jeste; Yoram Barak; Subramoniam Madhusoodanan; Fred Grossman; Georges Gharabawi
Journal: Am J Geriatr Psychiatry Date: 2003 Nov-Dec Impact factor: 4.105

10. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

Authors: Henry Brodaty; David Ames; John Snowdon; Michael Woodward; Jeff Kirwan; Roger Clarnette; Emma Lee; Ben Lyons; Fred Grossman
Journal: J Clin Psychiatry Date: 2003-02 Impact factor: 4.384

10 in total

4 in total

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial.